The QualityStocks Daily Thursday, February 6th, 2020

Today's Top 3 Investment Newsletters

Insider Financial (LITH) +73.59%

QualityStocks (RHNO) +66.67%

StockMarketWatch (BLNKW) +46.87%

The QualityStocks Daily Stock List

Cordoba Minerals Corp. (CDBMF)

Mining Stock Valuator, Stock Day Media, OTC Markets, Uptick Newswire, Wallet Investor, Northern Miner, Macroaxis, GlobeNewswire, Dividend Investor, YCharts, Stockhouse, Dividend.com, OTC.Watch , Equities, Investing News, Morningstar, Proactive Investors, Investors Hangout, Seeking Alpha, Nasdaq, Geology for Investors, Market Screener, MarketWatch, Junior Mining Network, and TradingView reported previously on Cordoba Minerals Corp. (CDBMF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Cordoba Minerals Corp. is a mineral exploration company focused on the exploration, development and acquisition of copper and gold projects. It is exploring the San Matias Copper-Gold-Silver Project. This Project includes the Alacran deposit and satellite deposits at Montiel East, Montiel West and Costa Azul, positioned in the Department of Cordoba, Colombia. Incorporated in 2009, Cordoba Minerals is headquartered in Vancouver, British Columbia. The Company lists on the OTC Markets’ OTCQB.

Cordoba Minerals also holds a 25 percent interest in the Perseverance porphyry copper project in the State of Arizona, which it is exploring by way of a Joint Venture (JV) and Earn-In Agreement. In July of 2017, Cordoba Minerals acquired a 100 percent ownership interest in the San Matias Copper-Gold-Silver Project from High Power Exploration, Inc. (HPX). HPX is a privately owned, metals-focused exploration company led by mining entrepreneur Mr. Robert Friedland. HPX owns a roughly 70 percent interest in Cordoba Minerals.

The San Matias Copper-Gold-Silver Project consists of a 20,000 hectare land-package. It contains several known areas of porphyry copper-gold and iron oxide copper gold, and/or carbonate replacement deposit mineralization and gold veins. The Project is situated close to sea-level in an established mining district with top-notch access and infrastructure.

The San Matias Project is an early stage exploration project. Cordoba Minerals is exploring a newly identified high grade copper-gold district that is characterized by porphyry type and “carbonate replacement” (CRD) type and/or “iron oxide copper-gold” (IOCG) type deposits formed in an accreted island arc setting. Late Cretaceous ages for the magmatism and mineralization are based on preliminary radiometric age dates.

Cordoba Minerals announced in November 2019 that JCHX Mining Management Co., Ltd. (JCHX) agreed to make a strategic investment in Cordoba. JCHX acquires a 19.9 percent stake in the Company to advance the San Matias Copper-Gold-Silver Project.

Last month, Cordoba Minerals announced its forthcoming work program for this year at the San Matias Copper-Gold-Silver Project in Colombia and the Perseverance Copper Project in Arizona. At San Matias, the Company plans on speeding up development of the Alacran deposit. It has started the Pre-Feasibility Studies needed to secure the necessary Colombian mining approvals.

At the Perseverance Copper Project that it is exploring via a JV and Earn-In Agreement with Bell Copper Corporation, Cordoba Minerals has started a Magneto-Telluric (MT) geophysical survey. The aim of the MT survey is to close off the earlier-identified strong conductivity anomaly thought to reflect the southwestern edge of a concealed porphyry system.

Cordoba Minerals Corp. (CDBMF), closed Thursday's trading session at $0.087, off by 4.9076%, on 15,940 volume with 2 trades. The average volume for the last 3 months is 24,688 and the stock's 52-week low/high is $0.02666/$0.10621.

chart

eMARINE Global, Inc. (EMRN)

TipRanks, Real Investment Advice, StockPulse, TeleTrader, Wallmine, Market Wire News, TradingView, Street Insider, Wallet Investor, Stockhouse, Market Screener, InvestorsHub, Morningstar, Stockopedia, Nasdaq, GlobeNewswire, Global Banking and Finance, Stockwatch, Simply Wall St, and Financial Buzz reported beforehand on eMARINE Global, Inc. (EMRN), and today we report the Company, here at the QualityStocks Daily Newsletter.

eMARINE Global, Inc. is a top provider of information and communications technology (ICT) for the maritime industry. It provides solutions for the collection, integration and display of maritime information abroad and ashore through electronic means to enhance berth to berth navigation and related services. The Company formerly went by the name Pollex, Inc. It changed its name to eMarine Global, Inc. in August of 2017. Incorporated in 2001, eMARINE Global has offices in Ulsan and Seoul, South Korea.

eMARINE Global’s solutions provide the most efficient means to secure the safety of life at sea and to protect the marine environment. All products and services are offered through subscription, installation, updates and/or maintenance contracts.

eMARINE Global is working with a growing base of marquee customers to reach maritime ICT convergence by way of fully integrated products and services. The Company offers state-of-the-art e-navigation, marine Internet of Things (IoT), and marine big data solutions, primarily in Korea with near-term expansion into U.S. and Chinese markets.

eMARINE Global offers electronic chart display and information systems (ECDIS), a computer-based navigation system; and electronic navigation charts (ENC), which integrates position information from the global positioning system (GPS) and other navigational sensors, including radar, fathometer, and automatic identification systems. eMARINE Global also provides smart ship solutions, including intra-ship integrated gateway (ISIG), an intra-ship network; collision avoidance and optimal voyage systems; and remote maintenance and engine monitoring systems.

The Company engages in the distribution of overseas solutions, such as CARIS, a maritime GIS software; digital charts; and Hatteland, a maritime-specialized hardware. Moreover, it provides Aids to Navigation (AtoN) management systems consisting of maritime weather signals total management system, and e-A2N device.

Yesterday, eMARINE Global announced it was chosen as the preferred bidder for a large-scale vessel traffic system (VTS) project for the Korean Coast Guard. The Company will work with foremost domestic system integrators, including Daily Blockchain and STX Engine, to complete the VTS project. In addition, the project team will include worldwide surveillance solution providers, including SAAB, an eMARINE partner company, and Terma A/S. The Korean Coast Guard VTS project is budgeted at $14 million over two years.

With the negotiated terms of the contract, the project consortium will construct two VTS operating centers, one in Mokpo and one in Gunsan, both located on the southwest coast of Korea. The project will include three radar systems in Mokpo and two radar systems in Gunsan.

eMARINE Global, Inc. (EMRN), closed Thursday's trading session at $0.15, even for the day, on 100 volume. The average volume for the last 3 months is 1,806 and the stock's 52-week low/high is $0.0131/$4.00.

chart

The Marketing Alliance, Inc. (MAAL)

Zacks, OTC Adventures, Whale Wisdom, The Online Investor, Simply Wall St, MacroTrends, InvestorsHub, TipRanks, Capital Cube, Proactive Investors, Morningstar, AA Stocks, Street Insider, and Wallet Investor reported earlier on The Marketing Alliance, Inc. (MAAL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

The Marketing Alliance, Inc. (TMA) operates as a wholesale distributor of life insurance, annuities, and other financial service products in the U.S. The Company is a broad network of independent agencies (product distributors) whose aims are to maximize their profit and grow their business. TMA operates three businesses and provides support to independent insurance brokerage agencies, with a goal of providing members value-added services on a more efficient basis than they can attain individually. The Company’s commitment is to the Independence of Independents. TMA has its corporate headquarters in St. Louis, Missouri. The Company lists on the OTC Markets.

Regarding its other two businesses, TMA also owns an earth moving and excavating business and nine children’s play and party facilities. It operates family entertainment space in Florida, Illinois, Missouri, and North Carolina under the name of Monkey Joes. It provides construction, heavy equipment, as well as trenching services in Iowa.

TMA enables smaller agencies to offer services like the biggest agencies. TMA also enables the biggest agencies to become more efficient and agile. Through TMA, affiliates have a larger presence with more contracts, better contracts, underwriting support, marketing services, competition services and administrative support.

Affiliates also have increased independence and a minimized need for staff. General Agents who affiliate with TMA can offer producers more products and services and attract new producers from new markets without increasing expenses. Furthermore, TMA provides long term care insurance, disability insurance, and Medicare supplement products.

Regarding TMA Distributor Services for Life Insurance, the Company has its Business Service Center (BSC). The design of BSC is to help one off-load low margin cases, off-load cases when short staffed or overrun with applications or just out-source new business functions completely. BSC helps make fixed expenses variable so one can manage costs and concentrate on sales and marketing. Additionally, TMA’s Business Service Center allows one to avoid contract minimums.

The Marketing Alliance, Inc. (MAAL), closed Thursday's trading session at $2.72, even for the day, on 4,244 volume. The average volume for the last 3 months is 782 and the stock's 52-week low/high is $2.67000007/$3.02999997.

chart

Wallbridge Mining Company Limited (WLBMF)

Gold Stock Data, hot Stocked, Penny Stock Hub, Wallmine, Investor Place, Stockwatch, Barchart, Northern Miner, OTC Markets, moneyhub.net, Investors Hangout, Wallet Investor, Dividend.com, Seeking Alpha, GuruFocus, Dividend Investor, and Stockhouse reported previously on Wallbridge Mining Company Limited (WLBMF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Wallbridge Mining Company Limited engages in the acquisition, discovery, development, and production of metals. It is establishing a pipeline of projects that will support sustainable 100,000 ounce-plus annual gold production as well as organic growth via exploration and scalability. At present, the Company is developing its 100 percent-owned Fenelon Gold Property. Wallbridge Mining has its head office in Lively, Ontario.

The Fenelon Gold Property is situated proximal to the Sunday Lake Deformation Zone, an emerging gold belt in northwestern Quebec with an ongoing 100,000 to 120,000 meter exploration drill program in 2020 and a 33,500-tonne bulk sample and 75,000 meters of drilling completed last year. Additionally, Wallbridge Mining is pursuing additional advanced-stage projects that would add to its near-term project pipeline.

The Company is also the operator of, and a 20 percent shareholder in Loncan Canada Inc. Loncan is a privately-held company with a large portfolio of nickel, copper, and PGM projects in Ontario's Sudbury Basin.

Wallbridge Mining is targeting Free Cash Flow from Operations and growth via exploration and acquisition. The Company’s 3-year goal is +60KOz Au per year Sustainable Producer. Its 5-year Goal is +100KOz Au per year Sustainable Producer.

Last week, Wallbridge Mining announced the intersection of 43.47 g/t Au (23.57 g/t Au cut) over 19.00 meters in the Lower Tabasco Zone on its Fenelon Gold Property. This interval is about 120 meters below the intersection of 22.73 g/t Au (18.87 g/t Au cut) over 48.01 meters in hole FA-19-086 and highlights the excellent potential for similar exceptional, high-grade intersections within the Lower Tabasco Zone.

Two additional holes from the continuing 2020 drill program also intersected intervals of visually strong mineralization with abundant visible gold in the Lower Tabasco Zone. Hole FA-20-110 returned a 120-meter core length interval with a number of mineralized zones, six containing visible gold, in the Andromeda-Tabasco-Cayenne corridors. Hole FA-20-115 cut a 16-meter core length interval of the Lower Tabasco Zone, roughly 23 meters below the FA-19-086 intersection.

Wallbridge Mining Company Limited (WLBMF), closed Thursday's trading session at $0.70, even for the day, on 363,067 volume with 83 trades. The average volume for the last 3 months is 541,108 and the stock's 52-week low/high is $0.160199999/$0.750199973.

chart

BLOK Technologies, Inc. (BLPFF)

Awesome Penny Stocks, BlockchainStocks, Cantech Letter, The Hot Penny Stocks, Growstox, TeleTrader, Stockwatch, Investing News, Wallet Investor, Stockhouse, GlobeNewswire, and Blockchain Relations reported previously on BLOK Technologies, Inc. (BLPFF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

BLOK Technologies, Inc. invests in and develops emerging companies in the blockchain technology sector. It provides capital, technology, and management services to produce blockchain-enabled business applications. BLOK’s present portfolio includes Greenstream and VR Eyes Technology Corp. The Company formerly went by the name Aida Minerals Corp. It changed its name to BLOK Technologies, Inc. in January of 2018. BLOK Technologies is headquartered in North Vancouver, British Columbia.

The Company provides reliable and established opportunities for investors desiring to invest in blockchain technologies without the volatility. The Company enables investors to capitalize on opportunities in this developing sector without the exposure and risk of unproven investment approaches such as ICO’s (Initial Coin Offerings).

BLOK Technologies’ method is to identify early-stage technologies with the potential to disrupt and innovate within their chosen industry. BLOK defines their opportunity, assesses their requirements, and provides them with the required financing and expertise to ensure the success of their projects.

The Company’s initial acquisition is Greenstream. Greenstream is the only consortium blockchain network for all companies, consumers, and government agencies in the Canadian Cannabis ecosystem to communicate and transfer assets and value. This is while complying with jurisdictional regulations. Fundamentally, Greenstream is a technology platform designed to effectively manage value transfer, supply chain integrity and identity verification in complex and highly regulated industries.

VR Eyes Technology Corp. is a new company that is researching and developing technology for eye care. VR Eyes Technology is focused on products that make detecting eye functions more convenient for the day to day user.

At the end of October, BLOK Technologies announced the appointment of Mr. Wilson Su to the Board of Directors and as Interim Chief Financial Officer of BLOK Tech, which was effective immediately. Mr. Su has more than a decade of investing experience, ranging from public markets to private real estate transactions. He concentrates on commercial real estate, with a specialty in land assembly on behalf of large development companies in the lower mainland of British Columbia.

BLOK Technologies, Inc. (BLPFF), closed Thursday's trading session at $0.008, up 33.3333%, on 15,204 volume with 2 trades. The average volume for the last 3 months is 34,024 and the stock's 52-week low/high is $0.0015/$0.024399999.

chart

Edgewater Wireless Systems, Inc. (KPIFF)

OTC Markets, Stockhouse, StockPulse, TalkMarkets, Capital Cube, Stockwatch, Insider Tracking, Trading View, GuruFocus, Wallet Investor and MarketWatch reported earlier on Edgewater Wireless Systems, Inc. (KPIFF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Edgewater Wireless Systems, Inc. focuses on Wi-Fi infrastructure with its patented WiFi3™ technology and Next Generation Access Points. The Company commercializes innovative wireless technologies for the service provider market. It is developing considerably improved Wi-Fi network performance across an array of industries and challenging environments with top-notch performance, high flexibility, and consummate security. Established in 1988 by Edgewater Computer Systems, Edgewater Wireless Systems is based in Ottawa, Ontario. The Company lists on the OTC Markets Group’s OTCQB.

Edgewater Wireless Systems has two distinct directions. One is in the Enterprise market, where the Company has validated its unique technology design with players such as Kroger and Mediacom. The second is the massive Consumer (Home) market where Edgewater has made major progress with its alliance with CableLabs.

Edgewater Wireless has a global distribution network and the Company has invested greater than $50 Million in the development of Edgewater Wireless Products. It has sales partners in the United States, the United Kingdom (UK), Brazil, Peru, and Asia.

Edgewater Wireless is patented, standards-compliant Wi-Fi delivering many simultaneous channels of transmit and receive on a single radio in 2.4GHz & 5GHz – called Wi-Fi Spectrum Slicing. MCSR powers its products. Edgewater Wireless WiFi3™ powered access point products enable unique service providers to plan, build, and deploy reliable, high-capacity services (such as VoWiFI) for high-density & data demand in any environment.

Edgewater delivers the highest channel density available on the contemporary market. It uses Edgewater Wireless patented technology, which enables numerous channels on a single chip. Accordingly, aggregate output on a single WiFi3™ powered AP will outperform traditional, single channel APs.

Edgewater Wireless Systems has released a powerful new Wi-Fi Spectrum Slicing Development Kit powered by Edgewater’s MCSR™ chipsets. The Company’s pioneering Dev Kit 2.0 delivers a complete hardware and software package for open source developers to create an ecosystem of apps unlocking the power of Spectrum Slicing to the residential and enterprise Wi-Fi markets.

Mr. Andrew Skafel, Chief Executive Officer of Edgewater Wireless Systems, said, “The latest release of our Dev Kit builds on the success of our earlier release, which was instrumental in securing our first enterprise design-win. We’re excited and proud to offer our latest Dev Kit and expect there is a myriad of applications to be developed.”

Edgewater Wireless Systems, Inc. (KPIFF), closed Thursday's trading session at $0.046, up 23.889%, on 52,000 volume with 4 trades. The average volume for the last 3 months is 25,865 and the stock's 52-week low/high is $0.029999999/$0.115000002.

chart

U.S. Lithium, Corp. (LITH)

TipRanks, StockInvest.us, Investor Place, Capital Cube, Stock Market Watch, Junior Mining Network, Investing.com, Infront Analytics, Morningstar, Wallet Investor, TradingView, Last10k, Equities.com, Dividend Investor, Emerging Growth, Stockhouse, Simply Wall St, Barchart, MarketWatch, and GlobeNewswire reported earlier on U.S. Lithium, Corp. (LITH), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

U.S. Lithium, Corp. is an exploration and development company listed on the OTC Markets. The Company is focused in North America on lithium and related resources for the fast growing energy storage industry. The Company was previously known as Rostock Ventures Corp. It changed its name to U.S. Lithium, Corp. in June of 2016. Established in 2006, the Company has its head office in Seal Beach, California.

At present, U.S. Lithium’s emphasis is in the Basin and Range province of Nevada. This is where the only producing lithium brine mine in North America, Albemarle’s Silver Peak Project, is located. Elon is U.S. Lithium’s first project. It is in Clayton Valley and is in close proximity to Silver Peak and a number of other active explorers and developers.

The ELON claim block comprises four 20-acre placer claims. ELON is situated in Esmerelda County, Nevada. It is contiguous to claims held by PURE Energy and Lithium X in Clayton Valley. PURE Energy and Lithium X are actively exploring their respective claim blocks in Clayton Valley.

U.S. Lithium also has its Gochagar Lake Ni/Co/Cu Project. The Gochagar Lake property has grades of up to 3.92% Nickel, 0.70% Copper, and 2.86% Cobalt as reported by the Province of Saskatchewan government (Mineral Property # 0880). U.S. Lithium is undertaking a complete digital compilation, reprocessing, and reinterpretation of all available data in and around the Gochagar Lake area.

Furthermore, U.S. Lithium focuses on the development of iWeedz.com. This is a search engine and e-commerce platform for cannabis information resources. It connects consumers with vendors.

In September of 2018, U.S. Lithium announced it renewed all of its lithium claims in the Clayton Valley of Nevada with the Bureau of Land Management (BLM). The projection is that lithium demand will triple by the year 2025 according to an earlier Goldman Sachs report.

U.S. Lithium, Corp. (LITH), closed Thursday's trading session at $1.63, up 73.5889%, on 659,008 volume with 909 trades. The average volume for the last 3 months is 51,072 and the stock's 52-week low/high is $0.109999999/$1.74.

chart

Adynxx, Inc. (ADYX)

TipRanks, TMXmoney, Xconomy, Street Insider, Investing.com, BioCentury, Stockhouse, Market Screener, TradingView, Stockopedia, Dividend Investor, GlobeNewswire, and PR Newswire reported previously on Adynxx, Inc. (ADYX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A clinical stage biopharmaceutical company, Adynxx, Inc. focuses on bringing to market novel, disease-modifying products for the treatment of pain and inflammation. The Company’s pipeline includes brivoligide, a Phase 2 drug candidate intended to address postoperative pain, and AYX2, a pre-clinical candidate intended to treat chronic syndromes of pain, including inflammatory and neuropathic pain. Fundamentally, Adynxx is a leader in transcription factor decoy technology. Established in 2007, Adynxx has its corporate headquarters in San Francisco, California.

The Company has worked since its founding to discover and develop transcription factor decoys to modify the course of pain, to collaborate with discovery partners, and to identify in-licensing opportunities with transformative therapeutic profiles to build a pipeline in pain and inflammation.

Adynxx is collaborating with twoXAR to use twoXAR’s artificial intelligence-driven drug discovery platform. This is to identify endometriosis treatments. In addition, Adynxx is evaluating in-licensing opportunities with transformative therapeutic profiles to treat pain and inflammation.

The AYX platform employs a proprietary technology of non-opioid, disease-modifying transcription factor decoys. AYX decoys are short DNA molecules, or oligonucleotides. They selectively inhibit transcription factors controlling the genes involved in the maintenance of pain. Therefore, a single administration of an AYX decoy generates a strong, long-term reduction of pain and associated clinical benefits.

Clinical studies suggest that a single administration of brivoligide at the time of surgery can safely lessen pain for weeks, speed up the time to attain mild pain and considerably decrease the need for opioid use during recovery specifically in patients at greater risk of experiencing increased and prolonged pain following surgery.

Recently, Adynxx announced that Mr. Gregory J. Flesher, Chief Executive Officer (CEO) at Novus Therapeutics, Inc. (NASDAQ: NVUS), was appointed to the Adynxx Board of Directors. Since May of 2017, Mr. Flesher has served as the CEO and a member of the Board of Directors of Novus Therapeutics, a specialty pharmaceutical company centered on developing products for patients with disorders of the ear, nose and throat.

For Q2 of 2019, Adynxx reported a Net Loss of $4.7 million, versus a Net Loss of $1.4 million for the same period in 2018. Research and development expenses were $1.9 million in Q2 of 2019, versus $0.6 million for the same period in 2018. This increase was mainly because of $0.7 million in connection with start-up activities related to Adynxx's planned Phase 2 ADYX-005 total knee arthroplasty and Phase 2 ADYX-006 mastectomy clinical trials and $0.7 million related to the initiation of drug supply manufacturing with Avecia, partially offset by a decrease in salaries and benefits from the resignation of an employee and other minor cost changes.

Adynxx, Inc. (ADYX), closed Thursday's trading session at $1.50, up 26.0504%, on 1,599 volume with 9 trades. The average volume for the last 3 months is 2,238 and the stock's 52-week low/high is $0.525099992/$21.8999996.

chart

Dajin Resources Corp. (DJIFF)

StreetWise Reports, Penny Stock Tweets, GoldTelegraph, The Prospector News, 24hgold, Metals News, Investing News, Junior Mining Network, BullMarketNews, 4-Traders, Mining Feeds, StockInvest, Simply Wall St, and OTC Markets reported earlier on Dajin Resources Corp. (DJIFF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Dajin Resources Corp., together with its subsidiaries, mainly engages in the acquisition, exploration, and development of mineral properties in Canada, the United States, and Argentina. An early stage Lithium brine exploration company, Dajin, via its interest in Dajin Resources S.A. (Dajin S.A.), holds concessions or concession applications in Jujuy Province, Argentina, which were acquired in areas known to contain brines with Lithium, Potassium and Boron values. Dajin Resources has its corporate headquarters in Vancouver, British Columbia.

The land holdings in Jujuy Province, Argentina exceed 93,000 hectares (230,000 acres). They are chiefly situated in the Salinas Grandes and Guayatayoc salt lake basins. Dajin S.A. is partnered with Pluspetrol Resources Corporation B.V. - as operator is required to spend $2,000,000 to earn a 51 percent interest in Dajin S.A. Lithium properties.

The Phase One exploration program of the 4,400 hectares (10,873 acres) in San Jose-Navidad minas has completed the program where 25 shallow brine samples were taken. The assays returned Lithium brine concentrations ranging from 281 mg/l to 1,353 mg/l averaging 591 mg/l.

In addition, Dajin holds a 100 percent interest in 403 placer claims encompassing 7,914 acres (3,202 hectares) in the Teels Marsh valley of Mineral County, Nevada. These claims are known to contain Lithium and Boron values. They are next to the birth place of US Borax Corp's first borax mine.

Furthermore, Dajin holds a 100 percent interest in 145 placer claims encompassing 2,921 acres (1,182 hectares) in the Alkali Spring valley (also called Alkali Lake valley) of Esmeralda County, Nevada, positioned 7 miles (11 kilometers) northeast of Albemarle's Silver Peak Lithium brine operation in Clayton Valley.

In November of 2018, Dajin Resources announced the signing of a Definitive Agreement with Cypress Development Corp. (TSX-V: CYP) (OTCQB: CYDVF) for the exploration and development of Dajin Resources’ Alkali Spring valley Lithium property in Esmeralda County, Nevada. This property is 12 kilometers (7.5 miles) northeast of Cypress Development’s Clayton Valley Lithium project in Nevada. With this Agreement, Cypress will have the exclusive right and option to acquire a 50 percent undivided interest in Dajin Resources’ unpatented placer mining claims and application for water rights in Alkali Spring valley, Esmeralda County.

Recently, Dajin Resources reported that Pluspetrol Resources Corporation B.V. acquired 100 percent of the issued and outstanding common shares of LSC Lithium Corporation (LSC) for a cash consideration of about CDN $111 million. Dajin was partnered with LSC who has, by way of its wholly-owned subsidiary Lithium S Holding Corporation, an earn-in agreement to spend CDN $2,000,000 to earn a 51 percent interest in Dajin Resources S.A. Pluspetrol has created the company Litica Resources S.A. for exploration and development of its concessions.

Dajin Resources Corp. (DJIFF), closed Thursday's trading session at $0.024, up 60.00%, on 109,000 volume with 10 trades. The average volume for the last 3 months is 106,251 and the stock's 52-week low/high is $0.010499999/$0.056000001.

chart

HIVE Blockchain Technologies Ltd. (HVBTF)

Micro Small Cap, TipRanks, Blockchain Stocks, FXStreet, Invest Tribune, Stockwatch, 4-Traders, Market Screener, Trading View, Insider Financial, Stockhouse, Simply Wall St, Smarter Analyst, Crypto141, Dividend Investor, Wallmine, Investors Hangout, InvestorsHub, and YCharts reported earlier on HIVE Blockchain Technologies Ltd. (HVBTF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

HIVE Blockchain Technologies Ltd. is a company building a bridge from the blockchain sector to traditional capital markets. The Company is strategically partnered with Genesis Mining Ltd. to build the next generation of blockchain infrastructure. HIVE’s corporate mission is to speed up the development of the blockchain sector via traditional capital markets and create long-term shareholder value. The Company’s shares trade on the OTC Markets Group’s OTCQX. HIVE Blockchain Technologies has its head office in Vancouver, British Columbia.

The Company’s deployments provide shareholders with exposure to the operating margins of digital currency mining and an increasing portfolio of crypto-coins. HIVE owns state-of-the-art GPU-based digital currency mining facilities in Iceland and Sweden that produce newly minted digital currencies such as Ethereum continuously as well as a cloud-based ASIC-based capacity that produces newly minted digital currencies such as Bitcoin.

HIVE Blockchain Technologies has an exclusive arrangement with Genesis Mining to operate its data centers under a Master Service Agreement. The data centers will be monitored with Genesis Hive, which is Genesis Mining's proprietary software tool for large-scale mining, to automatically optimize chip temperatures and power consumption for maximal coin production.

Regarding the Iceland Cryptocurrency Mining Project, HIVE’s launch transaction involved the acquisition of an initial state-of-the-art blockchain infrastructure facility in Iceland from Genesis Mining. This facility produces mined cryptocurrency around the clock. Assembly of the facility, which uses innovative computing components and infrastructure design, was completed in May of 2017. In Sweden, HIVE's GPU facilities were completed in April 2018 and are equipped with custom Genesis A2 mining rigs.

HIVE Blockchain Technologies launched the operation of an additional 100 PH of cloud-based ASIC Bitcoin mining on December 1, 2018. This brings the Company's digital currency mining footprint to a total of 24.2 MW of GPU mining and 300 PH of ASIC capacity.

Recently, HIVE Blockchain Technologies advised that on April 19, 2019, Genesis Mining, the largest shareholder of the Company, holding roughly 26.3 percent of HIVE's outstanding shares, requisitioned a meeting of shareholders for the purpose of removing directors independent of Genesis and electing a Board of Directors, the majority of whom would be senior officers and employees of Genesis Mining. On April 20, 2019, the HIVE Board met and appointed an independent Special Committee of the Board to deal with the requisition and related contractual disputes between Genesis and HIVE that gave rise to the requisition. HIVE stated the Special Committee will act in the interests of all HIVE shareholders and the Special Committee will set a date for the requisitioned meeting to be held within four months of proper delivery of the requisition notice.

HIVE Blockchain Technologies Ltd. (HVBTF), closed Thursday's trading session at $0.197, up 23.125%, on 3,225,062 volume with 701 trades. The average volume for the last 3 months is 567,345 and the stock's 52-week low/high is $0.058499999/$0.609000027.

chart

DXI Energy, Inc. (DXIEF)

Stockfuse, MarketWatch, InvestorsHub, Zacks, Oilandgas360, Tip Ranks, Wallet Investor, Stock Digest, Amigo Bulls, Dividend Investor, Stockhouse, Private Capital News Wire, Stockwatch, Equity Clock, The Street, Barchart, Marketwired, YCharts, Capital Cube, Street Insider, Marketbeat, ValueForum, and Seeking Alpha reported on DXI Energy, Inc. (DXIEF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

DXI Energy, Inc. is a tactical acquisitor and developer of strategic energy resources. The Company is an upstream oil and gas exploration and production company. DXI Energy operates in Colorado’s Piceance Basin and in the Peace River Arch area in British Columbia  (B.C.). DXI Energy has offices in Calgary, Alberta, and Vancouver, British Columbia. The Company’s shares trade on the OTC Markets’ OTCQB.

In Colorado’s Piceance Basin, DXI Energy has 24,407 net acres.  In the Peace River Arch area in B.C. it has 13,093 net acres. Concerning its project areas, in the Piceance Basin in northwest Colorado, DXI has its Kokopelli project with 12 producing wells with extensive in place infrastructure to supplement future development as product prices dictate. 

The Company’s land holdings in the Piceance Basin highlight potential long-term regional resource value. This is as utilities develop sources of natural gas. For Kokopelli, DXI Energy retains a 25 percent Working Interest (WI) in 2,200 acres (550 net, 2 leases). 

In addition, DXI has its Roan Creek project (West Piceance Hi-Pressure Mancos/Niobrara Gas). This project is 1,960 net acres, 100 percent WI. There is potential development of 8-10 high pressure Mancos/Niobrara 8200’ vertical/Hz wells.

The Woodrush Project in northeastern B.C. encompasses 14,444 net acres (20.701 (gross) with 12 wells (3 oil and gas, 9 natural gas). DXI is the operator and it owns 99 percent of the Project. The Company has a multi-phase plan to expand production and landholdings at the Woodrush Project. It has $13mm invested in production facilities and a related network of pipelines at the Woodrush Project.

Recently, DXI Energy announced that it received all B.C. Oil & Gas Commission (BCOGC) permits to begin the drilling of a key Halfway formation exploration well at its Woodrush NE B.C. complex. Contracts for the building of road access and an environmentally modified drill pad meeting specs of all First Nation stakeholders were issued; construction is underway.

Chief Financial Officer, Mr. David Matheson, said, "With the permit to drill from the BCOGC (inclusive of all other stakeholders), we will now test the voracity of the Paradigm 3D seismic imaging and interpretation software with the drilling and completion of this important Woodrush Halfway pool test prior to winter 2019 break up."

DXI Energy, Inc. (DXIEF), closed Thursday's trading session at $0.0264, up 27.5362%, on 21,765 volume with 6 trades. The average volume for the last 3 months is 21,366 and the stock's 52-week low/high is $0.017/$0.082000002.

chart

Rhino Resource Partners LP (RHNO)

Zacks, MarketWatch, Mining Connection, GlobeNewswire, Annual Reports, TopPennyStockMovers, Marketbeat, Simply Wall St, 4-Traders, Dividend Channel, Wall Street Mover, and PCG Advisory reported earlier on Rhino Resource Partners LP (RHNO), and today we report on the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Rhino Resource Partners LP is a diversified energy limited partnership. It concentrates on coal and energy related assets and activities. This includes energy infrastructure investments. Rhino is a diversified energy MLP (Master Limited Partnership). It produces coal in numerous basins in the U.S. Rhino Resource Partners has its head office in Lexington, Kentucky.

The Company, through acquisitions and other coal lease transactions, has substantially increased its proven and probable coal reserves and non-reserve coal deposits. Furthermore, Rhino has successfully increased its coal production by way of internal development projects.

The Company produces metallurgical and steam coal in an array of basins across the U.S. as well as leases coal. Rhino’s strategy is to acquire coal reserves and properties with relatively long lives and that could undergo development with low risk at a reasonable cost.

Rhino produces steam coal used to produce electricity and metallurgical coal used in the steel-making process. In addition, the Company manages and leases coal properties and collects royalties from such management and leasing activities. Rhino also has oil and gas investments in the Cana Woodford region that provides added cash flows to its business. 

In Central Appalachia, approximately 72 percent of its full-year 2019 thermal and met coal production has been contracted at increased prices in comparison to 2018. Rhino’s Pennyrile, Castle Valley and Hopedale operations are considerably sold out for 2019 at prices that are above the Company’s 2018 levels. Moreover, Rhino has executed long-term contracts with different utility customers for thermal coal for 2020 at Pennyrile and Castle Valley.

Rhino Resource Partners LP (RHNO), closed Thursday's trading session at $0.50, up 66.6667%, on 256 volume with 2 trades. The average volume for the last 3 months is 1,346 and the stock's 52-week low/high is $0.050299998/$1.50.

chart

HCi Viocare (VICA)

MarketWatch and Financial Times reported previously on HCi Viocare (VICA), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter. 

HCi Viocare focuses on the development and marketing of prosthetics and orthotics. The Company has a strong pipeline of near-market to research-stage technologies.  HCi Viocare has its executive office in Athens, Greece, and its research and development (R&D) center in Glasgow, Scotland, United Kingdom (UK).  The Company’s shares trade on the OTC Markets’ OTCQB.

HCi Viocare has two fully owned subsidiaries. One is HCi Viocare Technologies. The other is HCi Viocare Clinics. HCi Viocare Technologies is developing hardware solutions aiming to empower the user through providing on demand information and enhancing living quality. 

HCi Viocare’s business model consists of creating the first cross-border independent chain of Prosthetics & Orthotics (P&O) and Diabetic Foot clinics in Europe and the Middle East and developing an extensive portfolio of proprietary hardware solutions with first in line the Flexisense™ sensor system. The clinics will provide independent and personalized quality of care for its patients. The first HCi Viocare clinic has been operating since September 2015 in Glasgow.   

The R&D center is working on a large portfolio of progressive, cutting-edge, and disruptive technologies in the Digital Health, Prosthetics, and Orthotics, Diabetes, Assistive Devices and Sports & Wellbeing fields. HCi Viocare has developed a unique sensing technology with the brand name Flexisense™. 

Flexisense™ technology is the next generation of sensing technologies for wearable devices. Flexisense™ is an inventive sensing technology. It measures pressure and shear forces. In addition, it provides on demand information wirelessly. Flexisense can be incorporated in a wide array of applications. 

The Company has developed a new application for its sensing technology Flexisense™, now for automotive tires. Flexisense™ applied to tires can monitor, in real time, tire deformation and actual traction between the tire and the ground.

HCi Viocare Management, acknowledging the great advantages of Blockchain technology, has decided to develop its own proprietary Blockchain based system for handling the sensitive client records in its Scottish Clinics subsidiary. This team will develop a proprietary Blockchain based system for handling and storing the data produced from the medical applications of its Flexisense™ technology.

In October of 2017, HCi Viocare welcomed Dr. John Doupis, MD, PhD to its team. Dr. Doupis joined the Scientific Advisory Board assuming the role of Director of Clinical Matters and Diabetes. Dr. Doupis is a former Clinical Research Fellow of the Joslin Diabetes Center, Harvard Medical School, in Boston, Massachusetts, and Scientific partner in Beth Israel Deaconess Foot Center Harvard Medical School, Boston, Massachusetts. Dr. Doupis’ special areas of interest are Diabetes and its complications, particularly the Diabetic foot and Obesity.

HCi Viocare (VICA), closed Thursday's trading session at $0.09, up 56.5898%, on 1,335 volume with 3 trades. The average volume for the last 3 months is 3,686 and the stock's 52-week low/high is $0.009999999/$0.600000023.

chart

Tempus Applied Solutions Holdings, Inc. (TMPS)

MarketWatch and InvestorsHub reported on Tempus Applied Solutions Holdings, Inc. (TMPS), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Tempus Applied Solutions Holdings, Inc. provides design, engineering, systems integration, and flight operations solutions. These support critical aviation mission requirements for a variety of customers. The OTCQB-listed Company maintains a highly qualified and skilled in-house engineering team, which supports aircraft modifications, certification, maintenance,  and flight testing.

Tempus Applied Solutions,  LLC is the wholly-owned subsidiary of Tempus Applied Solutions Holdings; Inc.  Tempus Applied Solutions has its corporate office in Williamsburg, Virginia. The Company uses a secure facility with hangar and manufacturing space and secure communications at Brunswick Executive Airport. The facility has two parallel 8000’ x 200’ runways and a 4.5-million-square-foot ramp and taxiways - certified for B-747, A-340, and  and C-5 aircraft. 

Tempus has in-house DER (Designated Engineering Representatives) capabilities covering 41 categories of aircraft systems. Capabilities include Part 23 Aircraft and Part 25 Aircraft and also Repair Station DER. In addition, authorities encompass mechanical systems, electrical systems, and flight testing.

The Tempus Design & Engineering Center of Excellence has Designated Engineering Representative (DER) authority from the Federal Aviation Administration (FAA) and the European Aviation Safety Agency (EASA). This center’s specialties include major airframe modifications; interior completions projects; design and materials specifications; modeling and rendering utilizing 3D Max Vision; Supplemental Type Certificates (STC); and Layout of Passenger Accommodations (LOPA) Development.

Tempus flies airplanes - fixed wing and rotary, manned or unmanned. The Company engages in surveillance missions in Africa to flight training in Texas. Also, Tempus designs and modifies aircraft for special missions, certifies them, and provides turnkey lease and service solutions. 

Tempus operates Gulfstream, Bombardier, Pilatus, and Cessna aircraft. The majority of these aircraft have been specially modified by the Company for Department of Defense  (DoD)-related missions. This includes threat simulation, surveillance, communications relay, and diverse test and development programs.

The Tempus Applied Solutions subsidiary was awarded FAA  (Federal Aviation Administration)  approval, in the form of a Supplemental Type Certificate (STC), for Tempus' initial FANS/1-A and ADS-B compliance solution [(Tempus' "Solution AA")]. Tempus' solution received an "Approved Model List", or AML, STC. This means that it can be applied to any business and commercial aircraft.  FANS and ADS-B compliance will be mandated in most parts of the world by 2020.

Recently, Tempus Applied Solutions announced that it finalized the acquisition of six Lockheed L-1011s previously owned and operated by the Royal Air Force (RAF) of the United Kingdom. Four of these aircraft are specifically configured for air-to-air refueling (AAR) operations. The remaining two are configured for passenger and cargo operations only. The aircraft beforehand served the RAF and NATO.

Tempus Applied Solutions Holdings, Inc. (TMPS), closed Thursday's trading session at $0.1749, up 29.5556%, on 8,535 volume with 6 trades. The average volume for the last 3 months is 13,835 and the stock's 52-week low/high is $0.0601/$0.735000014.

chart

The QualityStocks Company Corner

Sharing Services Global Corporation (SHRG)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services Global Corporation (SHRG).

Sharing Services Global Corporation (OTCQB: SHRG), a diversified direct-selling company, is elevating the lives of independent representatives and consumers with branded health and wellness products that are scientifically formulated to elevate happiness and well-being by stimulating the brain to release key hormones. Two primary subsidiaries of SHRG work together for maximum shareholder value and to support the single objective of elevating lives: Elevacity Global LLC and Elepreneurs LLC.

Sharing Services Global Corporation (SHRG), formerly Sharing Services Inc., is a diversified company dedicated to maximizing shareholder value, operating through two primary subsidiaries: Elepreneurs Holdings, a direct-selling company, and Elevacity Holdings, a products company. Headquartered in Plano, Texas, SHRG markets and distributes Elevate-branded health and wellness products through an independent sales force of distributors called Elepreneurs.

Proprietary Products

SHRG’s current exclusive Elevate product offerings are marketed under the Elevacity brand, so named to signify the company’s commitment to elevating lives.

The Elevate health and wellness product line consists of nutraceutical products that SHRG refers to as D.O.S.E., which stands for dopamine, oxytocin, serotonin and endorphins – all of which are key hormones proven to promote happiness and well-being.

Elevacity brand products are carefully formulated, chosen and designed to support a single objective: elevate the happiness and well-being of the consumer.

Global Network of Elepreneurs

Elevacity products are shared and sold by a growing international network of home-based entrepreneurs, called Elepreneurs, operated by Elepreneurs Holdings. This SHRG subsidiary provides basic and advanced programs for both new and experienced entrepreneurs who are focusing on their direct-sales careers.

SHRG’s high-performing independent sales force follows the company’s Blue Ocean selling strategy, an approach that encourages individuals to seek new markets, lead, and to “stop competing and start creating.” The Blue Ocean strategy is based on the book, “Blue Ocean Strategy,” written by Professor Renée Mauborgne, who notes that “the lesson here is that the best defense is offense, and the best offense… is to make a blue ocean shift and create your own blue ocean.”

Following this selling strategy, SHRG’s Elepreneurs are taught that, rather than competing directly in a competitive, direct-selling market, they should focus on making competitors irrelevant and succeeding in an uncontested marketplace.

In addition, SHRG’s Elepreneurs use the interactive, video-based VERB sales-marketing platform developed by Verb Technology Company Inc. The app utilizes proprietary interactive video data collection and analysis technology and provides next-generation customer relationship management, lead generation, and video marketing software applications.

Continued Momentum as Industry Leader

These selling strategies have resulted in sharp and consistent revenue gains. In the company’s 10-Q filed with the SEC for the three months ended Oct. 31, 2019, SHRG reported sales of $38.8 million for fiscal Q2 2019, an increase of 116% over sales of $17.9 million reported for the comparable quarter of 2018. Consolidated gross profit jumped by $16.2 million to $27.4 million for the same period compared to Q2 2018.

SHRG’s consolidated operating earnings were $3.9 million in the fiscal quarter ended Oct. 31, 2019, compared to $866,802 for the comparable period the prior year. Consolidated gross margin also grew 70.9% for the three months ended Oct. 31, 2019, compared to 62.2% the prior year.

These numbers are continuing a trend established over the past two years. In fiscal Q1 2019, SHRG achieved revenues of $35.4 million, more than double that of the comparable period in 2018. Even earlier, the company reported sales of $85.9 million for fiscal year ended April 30, 2019. This represents a nine-fold increase, or $77.5 million jump, over the company’s revenues of $8.4 million the prior year.

These numbers bring SHRG’s sales revenues since December 2017 — when the company’s Elevate product line was released — to an impressive cumulative total of $169 million.

Preparing for Success

SHRG is well prepared to continue and accommodate for this growth. The company recently expanded its corporate footprint by moving to a 10,000-square-foot facility in Plano, Texas, that offers ample room to expand as the company grows and flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

In addition, the company has a seasoned, expert leadership team in place, led by John “JT” Thatch. Thatch was appointed president and CEO of SHRG in March 2018, bringing to the company his expertise obtained from successfully starting, owning and operating several businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist SHRG as the company aims to expand and increase revenues.

Contact
469.304.9400 x 201
Info@SHRGinc.com
http://www.SHRGinc.com

Sharing Services Global Corporation (SHRG), closed Thursday's trading session at $0.094, up 13.9394%, on 12,500 volume with 2 trades. The average volume for the last 3 months is 36,924 and the stock's 52-week low/high is $0.065800003/$0.3944.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint (OTCQB: SING) was featured on today's edition of the Cleantech and Climate Change Podcast. Issued by Investorideas.com, a global news source and leading investor resource covering cleantech and renewable energy stocks (Renewableenergystocks.com), the podcast covers today's problems and solutions for the future. To listen to the podcast, visit http://nnw.fm/8BsNJ. To view the full press release, visit http://nnw.fm/l9HKn. Also today, the company was highlighted in a publication from HempWireNews, examining how hemp has been dominating the conversation lately, especially in the agricultural communities, as the next great cash crop for American farmers. It is insanely versatile, said to have thousands of uses with applications in textiles, bioplastics, and construction being just a few of them. Unfortunately, the crop had been outlawed until very recently, and there’s a desperate need for accurate data about hemp if the industry is to flourish. Additionally, CannabisNewsWire reported that, following the recent announcement of newly appointed CFO Corey Lambrecht, SinglePoint Inc. (OTCQB: SING) President Will Ralston appeared in a television interview to discuss the company’s projected increase in 2020 profits through the activities of Direct Solar, its high-performing subsidiary that produced more than $2 million in revenue in the second half of 2019 (http://cnw.fm/Kx5DD ).

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed Thursday's trading session at $0.0084, up 2.439%, on 917,213 volume with 78 trades. The average volume for the last 3 months is 3,207,624 and the stock's 52-week low/high is $0.007/$0.023.

Recent News

chart

Sigma Labs Inc. (NASDAQ: SGLB)

The QualityStocks Daily Newsletter would like to spotlight Sigma Labs Inc. (SGLB).

Forecast to see explosive growth in the automotive industry by the year 2030, additive manufacturing (3D printing) provides numerous benefits to auto manufacturers. Much of the anticipated growth is expected to come from end-use parts production, an area where Sigma Labs Inc. (NASDAQ: SGLB), the only known producer of quality assurance software for the commercial 3D-printing industry, may provide significant advantages.

Sigma Labs Inc. (SGLB) is the only provider of in-process quality-assurance software to the commercial 3D printing metal industry that enables operators of machines making 3D metal parts to offset emerging quality problems, sustain part quality, and avoid rejects. Sigma’s software is the singular solution that enables both real-time, in-process detection of quality control manufacturing irregularities for critical metal parts and then provides the operator the actionable information needed to adjust and mitigate the developing anomaly. Sigma Labs’ software represents a paradigm shift in the quality control process for the manufacture of 3D printed metal components. The nascent 3D metal printing industry is on the verge of radically altering the speed and technical complexity of manufactured parts. Further, it makes possible just-in-time availability of critical components – all at reduced cost, time, waste and weight. 3D printing, heralded as the fourth industrial revolution in manufacturing, will only truly surpass traditional techniques when the additive manufacturing industry moves from “post process” quality control to “in process” quality assurance.

For the industry to move from prototype manufacturing of critical components to economically viable commercial production, the 3D metal printing industry must find ways to dramatically increase production speed and quality yields, and to dramatically decrease the excessive cost of quality control. To achieve these prerequisites and move 3D metal printing into the mainstream, parts must be inspected and certified during the manufacturing process rather than after. Parts in the production process that are developing signs of quality control problems must be identified in real-time and alerts must be issued. The problem, along with the solution, must then be communicated to the machine operator to implement repairs.

Revolutionizing Additive Manufacturing

Sigma Labs, with its PrintRite3D® brand, has established a new benchmark in the development and commercialization of real-time computer aided inspection (“CAI”) solutions. Sigma Labs resolves the major roadblocks and costly quality control challenges that impede the 3D manufacture of precision metal parts. The company’s breakthrough computer-aided software product revolutionizes commercial additive manufacturing, enabling non-destructive quality assurance during production, uniquely allowing errors to be corrected in real-time.

Sigma Labs was founded in 2010 by a team of Los Alamos National Labs scientists and engineers to develop and commercially license advanced metallurgical products for the military ordinance, dental implants, and then for additive manufacturing (3D printing). After assessing 3D metal printing technology and the costly, inconsistent quality control issues, Sigma Labs concluded that the enormous potential of 3D metal printing could only scale up if in-process quality-assurance tools were developed to observe, manage and control the manufacturing complexities in such a manner that reliability and repeatability of very high precision quality metal parts could be achieved in the process. Sigma Labs’ patented and third-party validated software has achieved these objectives and now delivers the critical elements needed to unleash the promise of 3D metal printing.

Sigma Labs’ products and services are engineered, manufactured and qualified for use in the highly demanding and hyper precise production environments of the aerospace, defense, transportation, oil and gas, biomedical and other precision-dependent industries.

The Challenge

Additive metal manufacturing combines multiple processes and parts into one single 3D printed part. Due to variances in the additive manufacturing process, parts of consistent quality currently can’t be reliably produced in either large or small quantities without substantial postproduction inspection and rejection costs. Parts are inspected after production using CT scans and other means, so the manufacturer doesn’t know until the very end which of the finished parts meet design specifications. This means lost time, lost profits and inability to economically scale up production.

Innovative Approach

Sigma Labs solves this problem with its patented, in-process quality control technology that informs operators and engineers how to improve both the manufacturing process and quality by capturing meaningful data about inconsistencies in real-time. Sigma Labs is also partnering with OEMs, working toward the visionary introduction of revolutionary closed-loop control that will bypass the machine operator and automatically make in process corrections by reducing machine variations.

Sigma Labs’ next generation technology gives manufacturers the ability to make fast, virtual real-time adjustments so that each finished part is uniform and within critical specifications, thereby improving production quality, decreasing end-users’ risks and waste, and increasing profits and speed to market. Sigma Labs’ PrintRite3D® IPQA Software monitors and assesses the quality of each production part in the 3D additive manufacturing process – layer by layer, and in real-time. This has never been available until now.

Sigma Labs maintains a strong intellectual property portfolio consisting of trade secrets, process know-how and 34 patents either granted, pending or awaiting pre-publication around the globe. These patents encompass the fundamental technologies underlying Sigma Labs’ melt pool process control, data analytics, anomaly detection, signature identification, and future “closed-loop control” of 3D metal printing.

Market Opportunity

Providing advanced quality assurance software to the commercial 3D printing industry is currently a $1.4 billion addressable market expected to grow to $3.9 billion by 2023. Integrating Sigma Labs’ groundbreaking software helps arm the industry with a necessary catalyst to help enable and optimize the fourth industrial revolution in manufacturing.

Sigma Labs’ global client base includes 23 installations across 19 different users. Tier-1 OEM enterprises and end-users such as Siemens, Honeywell, Pratt & Whitney and others are currently evaluating PrintRite3D® for production lines.

Management Team

John Rice, CEO and chairman of the board of directors, has extensive experience as a CEO, lead negotiator, turnaround expert, business financier and crisis management executive/consultant. Prior to becoming chair and CEO of Sigma Labs, he was the CEO of a successful turn-around of a Coca-Cola Bottling Company. Rice has led a variety of companies in diverse business sectors and worked on a host of products and technologies including design and manufacture of high-end jet engine test equipment for the U.S. Airforce, chaff dispensers for F16s, software for modeling naval exercises, software for controlling warehouse distribution systems, medical radioisotopes, cancer detection, and cybersecurity. He is an honor’s graduate of Harvard College.

Darren Beckett, CTO, has over 20 years of experience in the semiconductor industry, including Intel Corporation, where he held various technical and managerial positions. His expertise in process engineering for advanced manufacturing technology includes statistical process control for fabrication of semiconductor devices.

CFO Frank D. Orzechowski also serves as treasurer, principal accounting officer, principal financial officer and corporate secretary. He has more than 30 years of distinguished financial and operational experience. Orzechowski began his career at Coopers & Lybrand in 1982, received his CPA certification in 1984, and received his Bachelor of Science in Business Administration with a major in accounting from Georgetown University in 1982.

Ronald Fisher, vice president of business development, is leading the commercialization of PrintRite3D® 5.0. Fisher is a mechanical engineer with hands-on experience in quality, manufacturing and product development. He has distinguished himself as a lead sales and marketing officer as well as a chief operating officer most recently before joining Sigma in technology startup that grew from market entry to successful exit by merger-acquisition.

Sigma Labs Inc. (SGLB), closed Thursday's trading session at $1.02, off by 0.970874%, on 19,237 volume with 78 trades. The average volume for the last 3 months is 118,500 and the stock's 52-week low/high is $0.451099991/$2.45000004.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

British Columbia-based, biodelivery technology developer Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) is committed to the idea that better alternative methods for drug delivery exist than inhalation. To view the full article, visit http://cnw.fm/95Fyc. Also today, the company was featured in the 420 with CNW by CannabisNewsWire. The establishment of a program meant to provide marijuana permits to people who have been affected by the war against drugs in Los Angeles has been marred by delays, scandal, and bureaucratic blunders. This has resulted in the loss of thousands of dollars for some of the intended beneficiaries.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary DehydraTECH™ technology for improved taste, rapidity and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECH technology to improve taste, remove odor and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada and the United States. Lexaria has also developed its own hemp-oil brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea and supplements. These brands include ViPova™, TurboCBD™ and ChargD+™.

Virtually unique across both the hemp and the cannabis industries, Lexaria has successfully entered into a R&D and product development partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Only a small handful of hemp or cannabis-related companies have achieved formal relationships with Fortune 500 industry leaders, demonstrating the wide applicability of Lexaria’s technology.

In June 2019, building on its original 2015 independent, third-party laboratory in vitro lab experiments, which confirmed the absorption levels of cannabidiol (“CBD”) into human intestinal cells rose by 499% through the utilization of the DehydraTECH technology, Lexaria completed a series of animal studies using an enhanced formulation of its DehydraTECH technology. The results of the animal studies using the enhanced DehydraTECH formulation showed an increase of CBD delivery into the blood when compared to generic industry MCT coconut-oil formulations by 811%. In addition, the animal studies also showed delivery of 1,937% more CBD into animal brain tissue after 8 hours using the enhanced DehydraTECH technology when compared to generic industry MCT coconut-oil formulations.

Lexaria also has completed the first phases of its collaborative research program with the Canadian government’s National Research Council (the “NRC”) under which several studies were designed to optimize Lexaria’s DehydraTECH technology, enabling delivery of API’s within foods, beverages, capsules and other ingestible formats. These studies investigated the lipophilic active agent classes including cannabinoids, vitamins, NSAIDs and nicotine using advanced analytical techniques, including mass spectrometry and nuclear magnetic resonance testing, with the results of the studies confirming that Lexaria’s DehydraTECH technology did not create any covalent-bonded new molecular entity (“NME”). Whenever an NME is created, regulatory bodies such as FDA and Health Canada routinely require extensive health, safety and efficacy studies prior to that product’s release into the marketplace. That the NRC program failed to find evidence of an NME suggests products utilizing the DehydraTECH technology may require a less burdensome regulatory pathway.

Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: hemp/CBD; pharmaceutical; cannabis; and nicotine. In August 2019, Lexaria was issued its cannabis research and development licence from Health Canada which will allow Lexaria to continue its further investigations in-house of its DehydraTECH technology in connection with cannabinoids, along with ongoing work with vitamins, NSAIDs, PDE5-inhibitors, nicotine and other molecules.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the August 2019, the company’s patent portfolio includes ~60 patent applications filed and pending in more than 40 countries around the world; and 16 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally by the end of 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others. Lexaria’s granted patent portfolio related to cannabinoid delivery is one of the largest in the world.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology to third-partners and has signed licensing agreements with start-up companies as well as with a Fortune 100 industry leader. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed Thursday's trading session at $0.465, off by 4.0446%, on 43,575 volume with 78 trades. The average volume for the last 3 months is 105,925 and the stock's 52-week low/high is $0.3037/$1.57000005.

Recent News

chart

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

During a recently MoneyTV interview, ChineseInvestors.com (OTCQB: CIIX) CEO Warren Wang announced that the company will be launching a breakthrough CBD product in March. An article discussing the company reads, “One important aspect of the company’s strategy to increase profit is to sell its new CBD product through e-commerce using different social media platforms in 2020. To view the full article, visit http://cnw.fm/5ZJYz. Also today, the company was highlighted in a publication from CBDWire, examining how hemp is stuck in a peculiar position, from a legal point of view. The crop had been outlawed for decades before the 2018 Farm Bill legalized the cultivation and sale of industrial hemp and its extracts. While the legislation made hemp legal, it wasn’t comprehensive enough to regulate the industry that quickly grew around hemp.

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed Thursday's trading session at $0.154, off by 6.6667%, on 108,114 volume with 19 trades. The average volume for the last 3 months is 51,691 and the stock's 52-week low/high is $0.150000005/$0.51999998.

Recent News

chart

Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE)

The QualityStocks Daily Newsletter would like to spotlight Pacific Rim Cobalt Corp. (OTCQB: PCRCF).

Pacific Rim Cobalt Corp. (CSE: BOLT) (FRANKFURT: NXFE) is pleased to announce a non-brokered private placement (the “Offering”) for aggregate gross proceeds of $742,164.48. The Company intends to use the net proceeds from the Offering to fund development of its nickel-cobalt business in Indonesia as well as general working capital purposes.

Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) is a Canada-based exploration company focused on the acquisition and development of production-grade cobalt deposits, a key raw material input for the growing lithium-ion battery industry.

Pacific Rim Cobalt and its Cyclops Nickel-Cobalt Project, located in the Depapre District, Jayapura Regency, Papua Province, Republic of Indonesia, is uniquely positioned in a region with potentially the largest source of cobalt outside of Africa. Strategically located near China, the world’s largest cobalt buyer, the Cyclops Project is a laterite (iron-hosted) mineral prospect, rich in cobalt and nickel. Cobalt consumption in China is on-track to use over 8,000 tonnes of cobalt annually by 2021 for electric vehicle production alone and is projected to remain the world’s largest cobalt consumer for many years to come.

Global demand for renewable power is fueling a massive shift from traditional energy supply chain economics to cobalt-reliant lithium-ion batteries, the world’s most widely used power source for portable applications such as electric vehicles and other high-tech applications.

Pacific Rim Cobalt management has concluded that strategic access to major markets offers the most important factor to servicing the rising demand for cobalt. The company’s acquisition of its initial asset in Indonesia offers near surface, strong nickel-cobalt mineralization in an area with excellent infrastructure including a nearby workforce, supplies, sealed roads, ocean access, nearby port facility and gentle topography. The project area, nestled on the north coast of Papua, Indonesia, establishes Pacific Rim Cobalt well within the economically attractive ocean-going transportation range to Asia and its lucrative, growing industrial markets.

Exploration efforts are currently focused on establishing a maiden compliant resource for the Cyclops project, both in historically identified and drill-tested prospects as well as previously unexplored areas of the claims. During the first nine months of 2018, the company focused on assembling the necessary agreements to access northern areas of the project hosting historically identified mineralized zones. Mapping, sampling and a mini-bulk sample within the mineralized zones has been completed, along with a small-scale program in the previously unexplored far southern area of the project. With surface access to priority targets now established, Pacific Rim Cobalt will initiate drilling and extract additional mini-bulk samples for further metallurgical testing.

“We are excited and optimistic about the unique possibility of developing this project into an asset that will add shareholder value and position the company to play a future role in the battery metals supply chain,” Pacific Rim Cobalt CEO Ranjeet Sundher recently stated (http://nnw.fm/u1HNs). “We expect the near-surface nature of cobalt/nickel mineralization at the Cyclops project will lend itself well to low-cost, logistically straightforward drilling. We thus anticipate the opportunity to undertake a resource calculation study, as well as ongoing metallurgy and process option testing, will present itself in the near future. It’s going to be a busy year ahead, and we look forward to getting the drills turning and building value.”

Pacific Rim Cobalt’s world-class management team includes Sundher, who has over 20 years of capital markets experience. Sundher is also president of Canrim Ventures Ltd., a Singaporean advisory firm specializing in early stage project finance and structure. He previously founded Indogold Exploration, a Jakarta-based mining service firm, and has raised over $40 million for companies in which he was a founder/partner.

Chief Financial Officer Steve Vanry has 25 years of professional experience in senior management positions with public and private natural resources companies, providing expertise in capital markets corporate finance, mergers and acquisitions, regulatory compliance, accounting and financial reporting.

Andre Talaska serves as country manager and technical supervisor. He has over 30 years of experience in the mining and exploration industry and has held senior positions with several companies in Australia and southeast Asia. Shakir Juffry, business development/engineering, is a chemical engineer and extractive metallurgist by background training who has over 20 years of experience in the Indonesian mining and minerals exploration field. Toto Suarto Sajali, operation and development manager, is a mining engineer with over 15 years of experience in Indonesian project assessment, development and operations.

Pacific Rim Cobalt Corp. (OTCQB: PCRCF), closed Thursday's trading session at $0.1387, off by 8.5695%, on 14,850 volume with 15 trades. The average volume for the last 3 months is 17,260 and the stock's 52-week low/high is $0.079999998/$0.259299993.

Recent News

chart

Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT)

The QualityStocks Daily Newsletter would like to spotlight Blue Hat Interactive Entertainment Technology (BHAT).

Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a producer, developer and operator of augmented reality ("AR") interactive entertainment games, toys and educational materials in China, today announced the launch of a new educational product, "Smart Screen Immersive Education Classes," that will be implemented in preschools in Fujian, China. To view the full press release, visit http://nnw.fm/2goU9.

Blue Hat Interactive Entertainment Technology (BHAT) is a cutting-edge creator, developer and operator of popular augmented reality (“AR”) interactive smart toys and educational games in China. Blue Hat’s mobile-connected entertainment platform connects physical items to mobile devices through wireless technologies, creating a unique interactive user experience in various mobile games, interactive educational materials and toys with mobile game features.

Blue Hat designs original toys and games that utilize augmented reality technology, motion capture technology, image recognition technology, voice control, light sense technology, infrared, levitation induction, and other trending scientific technologies to transverse the virtual with reality. Blue Hat creates a rich visual and interactive environment for users through the integration of real objects and virtual scenery. This combination provides users with a more natural form of human computer interaction, enhances a user’s perception of reality, and delivers a more immersive entertainment experience.

Proprietary Technology

Founded in 2010, Blue Hat’s proprietary technology, product research and development, marketing channels and brand operation are the cornerstones of the business. Blue Hat focuses on the combination of “online” and “offline” activity and the interaction between “entertainment” and “product” to create a high-tech entertainment platform combining mobile games and AR. With the help of computer graphics, motion capture technology, image recognition technology and visualization technologies, Blue Hat accurately “places” virtual objects into the physical world, creating a new and stimulating visual environment for users.

Blue Hat recently displayed a variety of its sci-tech products at the Guangzhou International Toy Exhibition in China including AR Racer, Elastic Bubbles, AR Space Track, AR Alloy Toy Car, AR Need a Spanking, 5D Animated Magic Aquarium, Bug Travelers, AR Picture Book and other interactive games and smart toys.

The company has multiple products in development including new generations of four primary product lines and two new product lines.

Patents and Copyrights

Blue Hat’s advanced AR technology in interactive entertainment is protected by 178 authorized patents with 44 patents in various stages of the application process.

Another 14 applications for Patent Cooperation Treaty, or PCT, have been filed for international patents. As of March 31, 2019, the company owns 645 copyrights for artwork, 71 registered trademarks and 27 software copyrights.

Sales and Marketing

There has been rapid growth in the toys and games industry in China over the last several years. Total retail sales of toys and games in China soared from RMB 111.8 billion in 2012 to RMB 276.5 billion in 2017 with an average annual growth rate of 19.9% in 2017. Blue Hat believes the company is well positioned with little competition as the toy industry rapidly shifts toward intelligent and interactive toys and games. Retail sales of electronic toys grew at 24% annually in 2017 while that of traditional toys grew at 7%.

In addition to a powerful ecommerce presence, Blue Hat has long-term relationships with partnered distributors that place the company’s AR interactive entertainment products into well-known international retail chains and retail outlets. Blue Hat’s integrated online and offline sales channels include e-commerce giants such as Amazon and Alibaba, retail chain stores and the company’s physical experience store located in Xiamen, China. Blue Hat plans to open or franchise approximately 100 additional stores in China by 2021.

Blue Hat’s community-based platform offers users a highly engaged and interactive community with online communication forums and offline social activities. The company advocates a new model of “teaching through lively activities” and combines AR technology with education, integrating its products into situational teaching, roleplaying and man-machine interaction. This novel educational experience helps realize optimal transformation of information, creating a knowledge and enhancing cognition.

Management

Director and CEO Xiaodong (Sean) Chen has over 20 years of experience creating, developing and producing toys and games related products. Chen earned his EMBA from Renmin University of China and has been chairman of the board of directors and general manager of Fujian Blue Hat Interactive Entertainment Technology Ltd. since August 2015.

CFO and Director Caifan, who has over 20 years of financial accounting and taxation experience, earned a degree in finance from Hunan University of Finance and Economics. He has served as director, deputy general manager and financial controller of Fujian Blue Hat Interactive Entertainment Technology Ltd. since August 2015.

Jianyong Cai, chief technology officer and director, has over 35 years of experience in data communication principles, communication network foundation, software engineering, communication network theory and technology and computer network architecture. He holds degrees in data communication principles, communication network foundation and software engineering from University of Science and Technology of China. He has been director, deputy general manager and chief engineer of Fujian Blue Hat Interactive Entertainment Technology Ltd. since January 2010.

Blue Hat Interactive Entertainment Technology (BHAT), closed Thursday's trading session at $1.41, up 12.8%, on 785,044 volume with 2,135 trades. The average volume for the last 3 months is 67,574 and the stock's 52-week low/high is $1.11899995/$6.25.

Recent News

chart

Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

Marijuana Company of America (OTCQB: MCOA), an innovative hemp and cannabis corporation, on Wednesday provided hempSMART's overview for global sales and its marketing strategy for 2020. HempSMART(TM) will be attending the USA CBD Conference at the Las Vegas Convention Center, taking place February 12 -15, 2020. The event will kick-off a global tour of industry-focused conferences enabling hempSMART to connect with more than 11,000 attendees in each regional city and position itself as an industry leader. To view the full press release, visit http://cnw.fm/8DfUn.

Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed Thursday's trading session at $0.043, up 6.1728%, on 1,125,208 volume with 147 trades. The average volume for the last 3 months is 856,695 and the stock's 52-week low/high is $0.023/$1.13999998.

Recent News

chart

GP Solutions (OTC: GWPD)

The QualityStocks Daily Newsletter would like to spotlight GP Solutions (GWPD).

GP Solutions, Inc. (OTC:GWPD), the developer of "GrowPods" – controlled environment automated micro-farms, announced it is adding to its management team and making changes to its Board of Directors. The company appointed Christina Kane as Director of Sales. Kane has extensive experience in business development and was director of a major franchise with over 300 stores. She established distribution channels in 40+ countries, and is expert in global manufacturing.

GP Solutions (OTC: GWPD) is developing scalable farming systems for soil-less indoor organic farming. The company’s GrowPods are automated micro-farms that use hydroponic technology and unique soil systems to cultivate the highest-quality specialty leaf crops. The system is designed and engineered for ease of use, allowing users to farm year-round in any location of the world, supporting the company’s mission to provide customers with the ability to cultivate their own organic “superfoods.”

GrowPod Design & Function

GrowPod is a modular, stackable and mobile vertical growing environment specifically engineered to maximize yield and automation. GrowPods are available as a vertical pod, stacker pod or custom-built pod.

The Stacker Pod is a certified organic soil system that offers growers multiple levels of planting in order to maximize space and produce options with different fruits and vegetables. The Vertical Pod utilizes a vertical hydroponic system. It is affordable, scalable, efficient, automated and sustainable. The output provides customers with fresh and clean produce year-round in any climate. The Custom Pod is built to suit the farmer’s specific crop and grow goals.

Each 320-square-foot GrowPod container will have an annual production capability of up to four times that of outdoor growing methods, dramatically increasing profitability to the grower. The controlled environment of the GrowPod ensures efficient power and water usage in growing a wide range of horticultural and agricultural products in all environments and climates.

Thanks to a combination of hydroponic and certified organic soil systems, crop yields are higher, faster, and more consistent that conventional means. Customers can enjoy an average of eight higher yield crop cycles anywhere in the world.

GrowPod Features:

  • Modular, stackable and mobile
  • Fully insulated, food-grade shipping container
  • Engineered for automation
  • Efficient LED lighting
  • Hydroponic or soil-based platforms
  • Proprietary air and water filtration
  • Climate-controlled
  • Remote monitoring

GP Solutions also offers many services to its customers, including:

  • Shipment and installation service of its shipping container farms
  • On-site training
  • Provision of custom planting and harvesting schedule
  • Provision of growing supplies, seeds, nutrients, packaging, branding and repair materials
  • On-site visits, on-call and scheduled maintenance, and re-supply
  • Remote monitoring and automated control of environmental nutrients, environmental growth factors (PH, temperature, light) and circulation
  • Technical assistance
  • Consulting and custom facility systems design

Competitive Advantage

GrowPods allow cultivation to take place year-round, which maximizes ROI. The systems are sealed from outside pathogens, contaminants, pesticides, and the result is clean and robust crop production.

GP Solutions also has a line of remarkable new proprietary soil mixtures and nutrient lines which contain no animal products. These products are vital, as many other soils and additives can contain harmful pathogens and contaminants that can cause crops to become tainted or fail rigorous testing.

Global Solution

GP Solutions has partnered with the world’s leading food nonprofit companies, including Feeding America, Seeds of Hope, Habitat for Humanity, Meals on Wheels America, L.A. Kitchen, and Farm Bread, to help insecure communities take control of their own food dependence using container farms.

GP Solutions (GWPD), closed Thursday's trading session at $0.61, even for the day, on 260 volume. The average volume for the last 3 months is 1,362 and the stock's 52-week low/high is $0.600000023/$21.00.

Recent News

chart

Genprex Inc. (NASDAQ: GNPX)

The QualityStocks Daily Newsletter would like to spotlight Genprex Inc. (NASDAQ: GNPX).

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company utilizing a unique, non-viral proprietary platform designed to deliver tumor suppressor genes to cancer cells, today announced its February 4, 2020 receipt of notice from The Nasdaq Stock Market LLC ("Nasdaq") indicating that the company has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) (the "Bid Price Rule") for continued listing on The Nasdaq Capital Market. Accordingly, the company has regained compliance with the Bid Price Rule and Nasdaq considers the matter closed. To view the full press release, visit http://nnw.fm/Fi5Dq.

Genprex Inc. (NASDAQ: GNPX) is a clinical-stage gene therapy company developing potentially life-changing technologies for cancer patients based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities.

Research and Development

Genprex holds a portfolio of 30 issued and two pending patents covering its technologies and targeted molecular therapies. The company’s research and development program is focused on identifying and developing leading-edge gene therapies that can be used alone or in combination with other therapies for treatment of cancer.

Genprex’s initial product candidate is Oncoprex™, an immunogene therapy for the treatment of non-small cell lung cancer (NSCLC). Oncoprex works by interrupting cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis (or programmed cell death) in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance.

Preclinical research is being conducted with the goal of developing Oncoprex to be administered with targeted therapies in other solid tumors, and with immunotherapies in NSCLC and other solid tumors. In addition, Genprex has conducted and plans to continue research into other tumor suppressor genes associated with chromosome 3p21.3, as well as other potential applications of the company’s immunogene therapy platform.

Clinical Trials

Genprex is currently conducting the second phase of a phase I/II clinical trial at the University of Texas MD Anderson Cancer Center in Houston. The company plans to expand its clinical program by adding a new clinical study evaluating Oncoprex™ in combination with a checkpoint inhibitor for treatment of Stage IV or recurrent NSCLC. In research presented at the 2017 Annual Meeting of the American Association of Cancer Research in Washington, D.C., Genprex’s collaborators showed that TUSC2 in combination with PD-1 checkpoint inhibition has a significantly greater anti-tumor effect in lung cancer than either agent alone. The research also shows that TUSC2 in combination with PD-1 blockade has synergistic activity in upregulating natural killer (NK) cells, correlating with prolonged survival in mice.

TUSC2 (Tumor Suppressor Candidate 2) is a tumor suppressor gene that is absent or deficient in cancer cells of many different cancer types.

The Market

Genprex technologies seek to bridge a critical gap by combining with targeted therapies and immunotherapies to provide treatments to large patient populations who would otherwise not be candidates for those therapies or who have become resistant to them. Genprex technologies are being developed to overcome genomic limitations which are inherent in targeted therapies and immunotherapies in order to provide new treatment solutions to large cancer populations, such as those with lung cancer.

Each year, more people die of lung cancer than of colon, breast and prostate cancers combined. NSCLC is the most common type of lung cancer, accounting for about 85 percent of all lung cancers, according to the American Cancer Society (“ACS”). Despite radical advances in drug development and novel therapeutic standards, survival for late stage lung cancer has not improved significantly in the past 25 years.

Senior Management

Chairman and Chief Executive Officer J. Rodney Varner, JD, is a co-founder of Genprex and has served in these roles since August 2012. He has more than 35 years of legal experience with large and small law firms and as outside general counsel of a Nasdaq-listed company. Varner has served as counsel in company formation, mergers and acquisitions, capital raising, other business transactions, protection of trade secrets and other intellectual property, real estate, and business litigation. He is a member of the State Bar of Texas and has been admitted to practice before the U.S. Court of Appeals for the Fifth Court and the U.S. Tax Court.

Julien L. Pham, M.D., MPH, is president and chief operating officer of Genprex. In March 2013, Dr. Pham co-founded RubiconMD, a healthcare IT company that connects primary care providers to specialists for additional guidance and opinions on medical cases and served as its chief medical officer. He has served on the faculty at Harvard Medical School’s Brigham and Women’s Hospital and is a board-certified internal medicine doctor and nephrologist.

Ryan M. Confer, MS, has served as Genprex chief financial officer since September 2016. Confer has more than 10 years of executive experience in planning, launching, developing, and growing emerging technology companies and has served in the chief operating and chief financial roles for non-profit and for-profit entities since 2008. Confer has also served as an international business development consultant for the University of Texas at Austin’s IC2 Institute, where he focused on evaluating the commercialization potential of nascent technologies in domestic and international markets applicable to technology incubator programs associated with the University. Confer holds a BS in finance and legal studies from Bloomsburg University of Pennsylvania and an MS in technology commercialization from the McCombs School of Business at the University of Texas at Austin.

Jan Stevens, RN, is vice president of Clinical Operations. Stevens has nearly 20 years of comprehensive clinical operations experience in the biopharma industry and a specialization in early-to-late stage oncology companies. Stevens joined the company to help support the various clinical development programs for Oncoprex™.

Genprex Inc. (NASDAQ: GNPX), closed Thursday's trading session at $1.33, off by 6.993%, on 2,149,605 volume with 4,121 trades. The average volume for the last 3 months is 3,475,480 and the stock's 52-week low/high is $0.231000006/$2.25999999.

Recent News

chart

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)

The QualityStocks Daily Newsletter would like to spotlight Canopy Rivers Inc. (RIV) (CNPOF).

Canopy Rivers Inc. (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, and its portfolio companies have made a series of recent announcements that include a board appointment for Canopy Rivers' President & CEO, one brand's retail launch in Canada, and a founder and portfolio company receiving awards for their accomplishments. Other Canopy Rivers portfolio companies hit the milestones required to help further expand and build out their facilities.

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) is the venture capital investment platform of Canopy Growth Corporation (TSX:WEED, NYSE:CGC).

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.

Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.

Canopy Rivers’ expanding portfolio includes:

  • Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
  • CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
  • Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
  • James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
  • LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
  • PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
  • Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
  • Solo Growth (TSXV:ALZ) is a new cannabis retail concept that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Solo Liquor Stores Ltd., a leading Canadian liquor retailer. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy.
  • Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
  • TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
  • Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.

As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.

Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.

Canopy Rivers Inc. (CNPOF), closed Thursday's trading session at $0.9689, off by 1.1327%, on 52,925 volume with 105 trades. The average volume for the last 3 months is 125,147 and the stock's 52-week low/high is $0.779999971/$3.99.

Recent News

chart

OriginClear (OTC: OCLN)

The QualityStocks Daily Newsletter would like to spotlight OriginClear (OTC: OCLN).

OriginClear (OTC: OCLN), a pioneer in decentralized water treatment and management, and Depuporc S. L., an OriginClear licensee and developer of an innovative and patented manure treatment system, today announced results of independent testing that further validate the effectiveness of Depuporc’s swine manure treatment system. According to the update, OriginClear published a new video with coverage of the model system and a testimonial by Eduardo Chopo, co-owner of Depuporc. To view the full press release, visit http://nnw.fm/Ggyr5

OriginClear (OTC: OCLN) leads the self-reliant water revolution, deploying advanced technologies at the point of use, with modular, prefabricated systems that create durable assets and water independence for industry, commerce and agriculture.

Failing infrastructure and the rising cost of water are driving businesses to treat their own water. OriginClear leads this megatrend with on-premise systems enabling very high purification and recycling levels that centralized systems cannot achieve.

Systems installed at the point of use become productive assets for businesses that also increase property values. And OriginClear helps corporations improve their environmental, social and governance (ESG) standings with world-class water management.

Operations & Markets

OriginClear leads a new generation of water companies that focus on meeting the needs of businesses looking for compact, advanced technologies that can be shipped to and installed at the point of use. The company manufactures and distributes its professional-grade water treatment and conveyance products to commercial and industrial properties, fielding both direct and indirect sales channels to reach end-market clients such as hotels and resorts, real estate housing developments, office buildings, military installations, schools, farms, food and beverage manufacturers, industrial warehouse, oil and gas producers, and medical and pharmaceutical facilities.

From its Texas-based factory, OriginClear designs and prefabricates an entire line of plug-n-play containerized units called Modular Water Systems™ that enable water purification, recycling and wastewater management.


Industrial Pretreatment Waste Water Treatment Plant (WWTP) designed by Daniel M. Early, using reinforced thermoplastic modules.

These onsite modular products provide clients with water independence through ownership and operational control over water quality, enabling them to increase productivity while reducing environmental, health and safety risks from pollution, contamination and corrosion. Modular water products are trusted to balance performance with cost-effectiveness, enabling business users to go well beyond municipal standards for water quality, therefore achieving high levels of satisfaction for their own customers, and improved sustainability for their properties.

OriginClear’s water treatment equipment can boost real estate asset value as a fundamental capital improvement, combined with long-lasting water savings for the corporate bottom line.

Product Portfolio

OriginClear groups its products into three main categories:

  1. Water Treatment: achieving high grade purification.
  2. Water Conveyance: water transportation and pumping.
  3. Advanced Technologies: commercialization of innovative technologies.

OriginClear’s complete line of compact, on-site, point-of-use products include: advanced purification systems that are skid, rack-mounted and containerized for reverse osmosis, ultrafiltration, media filtration, disinfection, water softening, ion exchange and electrodeionization (EDI), combined as needed in small to medium commercial and industrial applications, and custom-build projects. Water conveyance products include pump and lifting stations, modular storage tanks, and control monitoring panels.

OriginClear’s line of modular water products and systems is key to the self-reliant water treatment revolution as they create “instant infrastructure” – fully engineered, prefabricated and prepackaged systems that use durable, sophisticated materials. The units are available in standard capacities for onsite closed-loop systems at commercial business locations.

The company’s rugged wastewater treatment plants, highly reliable pump stations, and premium water purification units typically offer 25 percent lower initial costs over conventional systems, with greater quality and full connectivity. These pump stations and wastewater treatment products utilize high density thermo-plastics (HDPE) and proprietary, innovative prefabrication methods and materials that deliver the longest life and strongest products.

Breakthrough Technologies

OriginClear has a long history of innovation through its OriginClear Technologies division, which is responsible for identifying leading-edge technologies to solve today’s toughest challenges. These advanced technologies are the centerpiece of the division’s international licensee network. The technologies are developed in OriginClear Technologies, and licensees integrate them into their own products.

Electro Water Separation™ (EWS) and Advanced Oxidation (AOx™) are the principal, well-proven technologies.

EWS is OriginClear’s breakthrough water cleanup technology which utilizes a catalytic process to concentrate and eliminate suspended solids in the worst commercial and industrial wastewater.

AOx is OriginClear’s proprietary advanced oxidation technology which generates a dense cloud of ozone, hydrogen peroxide and hydroxyl radicals, dramatically reducing or eliminating dissolved organic microtoxins, including bacteria and viruses, hormones, drugs, pesticides such as Roundup, and synthetics. AOx has also been shown to effectively reduce harmful chemicals such as ammonia and hydrogen sulfide – the “rotten egg” smell in crude oil that reduces its value.

Through international licensing and partnerships, OriginClear’s advanced technologies are being adopted to treat tough water problems in East and South Asia, Europe and the Middle East, and North America.

Market Opportunity

In just 10 years, the global water services market has doubled into a trillion-dollar industry, driven by improper sanitation and water scarcity. Only 20 percent of all sewage and only 30 percent of all industrial waste are ever treated. Additionally, water leakage results in the loss of 35 percent of all clean water across the planet; reducing that percentage by half would provide clean water for 100 million people. This is a situation of great danger, but also great potential.

The statistics demonstrate that we can no longer rely on the efficiencies of giant, centralized water utilities to meet these challenges. An increasing number of businesses are starting to take notice, instead conducting their own water treatment and recycling. Whether by choice or out of necessity, those businesses that do invest in onsite water systems get a tangible asset on their business and real estate, and can enjoy better water quality at a lower cost.

Out of the public’s eye and with OriginClear’s help, a growing number of self-reliant businesses are building Decentralized Water Wealth™ for themselves while also helping their community. They know that environmental, social and governance (ESG) investing guidelines, which represent $22 trillion of assets under management around the world, specifically note the key indicator of how well corporations manage their water.


10,000 Gallon per Day Industrial Membrane Bioreactor Waste Water Treatment Plant designed by Daniel M. Early, PE, using long-lived Structural Reinforced ThermoPlastic (SRTP)

OriginClear is a key enabler of ESG water management for corporations that are increasingly responsible for what was once delegated to central utilities. For example, when a corporation manages its own water, and uses OriginClear’s proprietary hybrid treatment methods, it can significantly reduce both water use and nutrient footprints (carbon, nitrogen, and phosphorus) in one compact package.

These hybrid processes feature advanced blackwater treatment with advanced clean water processing. They can convert toxic nutrients to less harmful compounds, and even capture them for beneficial reuse purposes, as shown in OriginClear’s recent case study.

Revenue Growth through Synergy

Since OriginClear acquired it in 2015, Progressive Water Treatment has generated steady revenues in the range of a million dollars a quarter. It is now the Fabrication and Manufacturing Division for the whole company. The team at Modular Water Systems, headed by Chief Engineer Daniel M. Early, is responsible for overall design and high-level engineering. It relies on the Fabrication and Manufacturing Division to add incremental revenue for its modular product line, without requiring large increases in personnel.

OriginClear believes that these two business units can develop growing revenues through synergy and ultimately help achieve overall profitability. OriginClear also seeks to acquire profitable water companies that can complement the synergy of its existing units and accelerate both revenues and profitability. However, acquisitions are neither guaranteed, nor essential to OriginClear’s continued growth.

 

Leadership

OriginClear’s management team brings strong leadership and a background in managing business operations, sales, technologies, and finance. The team combines idealism with solid commercial skills, achieving a triple bottom line of environmental, social and financial gain.

Riggs Eckelberry – Chairman, CEO and Co-founder
Riggs Eckelberry is a veteran technology manager who led companies to multiple exits during the high-tech boom of the 90s and early 2000s. Eckelberry came to the water industry from a quarter century in high technology, specializing in commercializing breakthrough technologies. During the dotcom boom, he worked on a series of tech successes, such as Quarterdeck’s CleanSweep; security software vendor Panda Software; and the sale of companies to EarthWeb, BeFree, and BellSouth. Just prior to founding what is now OriginClear, he helped drive security software company CyberDefender to an IPO on the Nasdaq as its president and chief operating officer.

Thomas Marchesello – Chief Operating Officer
Thomas Marchesello is a business operations and technology executive with over 20 years’ experience in manufacturing and distribution of products and services. He has 12 years in private equity M&A, doing buyside acquisitions of small to midsize corporations. He has over 10 years advising innovative corporations on ESG strategy and speaks often about industry trends. He began his career in the U.S. Air Force, Space Command Headquarters for environmental sciences. He has held key roles for Fortune 500 companies such as Sony, Thompson Reuters, Morgan Stanley, and Chicago Mercantile Exchange.

Daniel M. Early, PE – Senior Engineer
For the past 25 years, Dan Early has worked as an engineered products development specialist with very strong understanding of the complex and interconnected disciplines, economies, and governmental regulation needed to develop and sustain modern civil infrastructure systems that reflect a balance of environmental stewardship, social expectations, and cultural requirements. Since 2010, Early has specialized in the research, development, and deployment of next generation water infrastructure technologies using heavy plastic manufacturing. His initiatives and innovations anchor Modular Water Systems’ product line.

Marc Stevens – Director of Fabrication and Manufacturing
Marc Stevens brings nearly 40 years of experience to OriginClear’s manufacturing team. His experience in mechanical design, equipment fabrication, installation and a wide range of projects led to his founding what is now OriginClear’s Fabrication and Manufacturing Division. He supervises the design, building and installation of customized, large-scale water treatment systems, including purification technologies for process waters for boilers and cooling towers, drinking water and various industrial waste water applications. Stevens leads the team that also manufactures OriginClear’s standardized Modular Water Systems.

OriginClear (OCLN), closed Thursday's trading session at $0.10385, off by 5.5909%, on 119,667 volume with 35 trades. The average volume for the last 3 months is 69,587 and the stock's 52-week low/high is $0.078749999/$4.00.

Recent News

chart

No Borders Inc. (OTC: NBDR)

The QualityStocks Daily Newsletter would like to spotlight No Borders Inc. (NBDR).

No Borders Inc. (OTCQB: NBDR) specializes in the acquisition, creation and scaling of commercial products by utilizing cutting-edge technologies designed to reduce costs while increasing revenues and shareholder value. With active subsidiaries in healthcare, education, cannabidiol (CBD), finance and technology, No Borders is uniquely positioned to use its expertise to improve margins and add business lines within target verticals. No Borders is headquartered in Arizona with remote work resources in the U.S., South America, Asia and Europe.

Different by Design

Deeply experienced at actionable data compilation, analysis and utilization, No Borders believes that data utilization in a Web 3 ecosystem of predictive analytics, blockchains, consensus algorithms, IoT and 5G are vital keys to the future of disrupting global business.

The company leverages its technological talent and visionary approach alongside best-in-class branding, messaging and product teams to simultaneously deploy multiple vertical product offerings at the same time.

With resources around the world, No Borders operates as a 100% remote work, lean operating organization with a founding ideological focus on “Lifestyle by Design.” No Borders’ teams are built by allowing people to work when they want and from where they want as long as deliverables and results are achieved. This structure allows for strategic talent acquisition without the need for relocation or commuting; lowered operating and fixed costs; as well as improved morale and substantially increased staff productivity.

NBDR Companies

  • No Borders Dental Resources Inc. provides equipment and supplies to medical and dental professionals across the U.S. through the trade name, MediDent Supplies. MediDent has a strategic focus on expanding product portfolios and optimizing lifetime customer value while minimizing customer acquisition cost in the medical, dental and veterinary spaces.
  • No Borders Naturals is a purveyor of health and wellness products for active consumers and their pets. No Borders Naturals aims to be an industry leader in alternative wellness product offerings and is currently expanding its digital offering with impactful product up-sell opportunities such as a series of “Buy Two-Get One” on products on its 1000mg CBD tincture, collagen and retinol beauty cream.
  • No Borders Labs Inc. provides leading-edge tech tools to the No Borders family of companies along with building, testing and deploying technology solutions and products to the market while also offering consulting, architecture and software development services to external businesses looking to update their technology infrastructure for greater efficiency, security and transparency.
  • No Borders Funding Inc. provides internal capital and strategic funding options for the family of No Borders companies while actively engaging and networking to find, acquire, structure and deploy unique financial products, solutions and systems with traditional, distributed ledger and blockchain technologies.
  • No Borders Education Inc. provides internal staff training and strategic education tools for the No Borders family of companies while pursuing external revenue generating educational opportunities within the verticals for which No Borders deploys products, services or technologies.

 

Leadership

No Borders CEO Joseph Snyder is a serial entrepreneur whose experiences in real estate investment, financial services and digital strategy over the last 15 years provide a strong, grounded foundation for the structure and ideas outlined in the company’s strategic plan. He brings a unique set of long-term business experiences that provide No Borders with a clear “mile-high” view of the intricately linked systems and challenges associated with growing and scaling our vision.

COO Cynthia Tanabe, a licensed real estate agent/broker since 2004, has successfully built a highly respected investor and bank-focused real estate and property management firm in Arizona with tens of millions of dollars of properties owned and sold.

CTO Chris Brown has 14 years of experience in the IT industry ranging from full stack programming, hardware support, engineering and maintenance, to enterprise-level information system analysis, design, development and implementation. From his background in Air Force intelligence to earning dual B.S. degrees in computational mathematics and biochemistry from Arizona State University, Brown has been engrossed with technologies such as artificial intelligence, machine learning, and decentralized blockchain ledger systems and their connections with real world business applications.

Management is backed by an advisory board with a diverse range of expertise blockchain, brand development, specialty retail, branded consumer products, technology, marketing and other specialties pertinent to No Borders’ growth strategy.

No Borders Inc. (NBDR), closed Thursday's trading session at $0.014, up 12.00%, on 27,699 volume with 6 trades. The average volume for the last 3 months is 108,554 and the stock's 52-week low/high is $0.007699999/$0.048799999.

Recent News

chart

Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF)

The QualityStocks Daily Newsletter would like to spotlight Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF).

Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF) is a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (“APIs”) and intermediates. The company’s cannabidiol (“CBD”) yeast-based biosynthesis program produces a high yield, ultrapure, low-cost and scalable manufacturing solution for pharmaceutical, food, beverage and personal care consumers of CBD.

The company is headquartered in Calgary, Alberta, Canada.

Biosynthesis Platform

Willow’s proprietary yeast-based lab strains produce CBD, tetrahydrocannabinol (“THC”), and cannabigerol (“CBG”), as well as certain minor and novel cannabinoids.

The company’s expertise in the esoteric field of biosynthesis and in delivering commercial fermentation pathways for the production of pharmaceutical-grade compounds grew from its origins in opiate research. Willow recently delivered a de novo biosynthesis pathway in yeast for thebaine, a key precursor API used as a feedstock in the manufacture of semi-synthetic opiates such as naloxone (used to reverse opioid overdose) and several common analgesics. Led by Chief Scientific Officer Dr. Peter Facchini, Willow’s research team discovered and patented numerous previously unknown genes coding for core catalytic pathway enzymes, as well as a number of additional non-pathway, yet commercially-essential, accessory genes.

Utilizing this proven synthetic biology platform, Willow’s research team has already begun producing cannabinoids at lab scale, using yeast as the host cell “factory.” This biosynthetic fermentation-based process is capable of producing pharmaceutical grade CBD in 10 days – far less time than traditional plant-based extraction methods.

Willow anticipates its technology can be scaled to produce hundreds of kilograms per batch of cannabinoid API at less than $1,000 per kilogram, thus costing approximately 60% less than current chemical synthesis methods and 90% less than conventional plant-based extraction methods.

World-Class Collaboration

Willow and Noramco Inc., the world’s largest producer of high-quality synthetic cannabinoid APIs and other controlled substance APIs for the pharmaceutical and healthcare industry, have an exclusive, worldwide Joint Development Agreement (“JDA”) to design a yeast-based biosynthesis platform for the production and distribution of a highly pure CBD isolate.

The mutually exclusive agreement calls for Willow to be responsible for optimizing yeast strains in a biosynthetic process to generate ultrapure CBD at high yield and substantially lower cost compared to current methods. Noramco will leverage its decades of experience in producing and delivering CBD and pharmaceutical APIs by being responsible for the scale-up, regulatory submission, marketing and distribution of products manufactured under the JDA.

Each company will invest comparable funds, will retain the intellectual property associated with their respective scopes of work and share equally in gross profits from sales of products manufactured under the JDA.

Market Opportunity

The agreement with Noramco (http://nnw.fm/Mz1vW) addresses the increasing demand for CBD-based APIs and other CBD-infused products by pharmaceutical, nutraceutical, consumer packaged goods, beverages and other industry sectors.

The U.S. market potential of cannabinoids is significant, with industry analysts projecting $50 billion in cannabinoid-based pharmaceutical sales and $16 billion in CBD consumer goods retail sales by 2025. As of June 2019, 34 U.S. states and the District of Columbia, Guam, Puerto Rico and U.S. Virgin Islands have legalized cannabis for medical use. Another 13 states and territories have approved recreational cannabis for adult use while other states are considering similar measures.

The cannabinoid API market continues to evolve with CBD and other cannabinoid-based treatment options currently in clinical trials for indications such as post-traumatic stress syndrome, epilepsy, Parkinson’s disease, chronic pain, schizophrenia, cancer treatments and other challenging unmet medical conditions.

Capitalization

Willow is fully funded after raising $29 million via private placement and $8 million in exercised warrants by Tuatara Capital Fund II, L.P. Proceeds of the funding will be used to enhance the existing laboratory space in Calgary and Vancouver, Canada, and in San Francisco, California. The company anticipates exiting 2020 with $15.8 million in cash.

Leadership

President and CEO Trevor Peters is an experienced executive who co-founded four startup companies in the past 15 years. He has raised over $1 billion in equity and debt financings at various stages of corporate development and has been integral to successful transactions totaling over $4 billion on sale. Mr. Peters previously was chief financial officer at Caracal Energy Inc., which sold to Glencore plc in 2014 for $1.8 billion.

Chief Financial Officer Travis Doupe has over 18 years of experience in financial leadership roles, principally in the international oil and gas industry, where he provided corporate strategic direction while overseeing all aspects of financial operations. Mr. Doupe is the treasurer and a member of the board of directors of the Canada Council for the Americas – Alberta and holds a CA-CPA designation and earned a bachelor’s degree in management from the University of Calgary.

Dr. Peter Facchini, Chief Scientific Officer, has been professor of plant biochemistry in the Department of Biological Sciences at the University of Calgary since 1995. He is recognized internationally as a leader in plant specialized metabolite biosynthesis. Dr. Facchini is the Canada Research Chair in Plant Metabolic Processes Biotechnology and has published more than 150 research papers and scholarly articles. Dr. Facchini received a PhD from the University of Toronto and conducted postdoctoral research at the University of Kentucky and Université de Montréal.

Dr. Joseph Tucker, Executive Chairman of the Board of Directors, holds more than 20 issued or pending patents and is a member of the Board of Directors of BioAlberta. He has extensive senior leadership experience in multiple public and private biotech companies. Dr. Tucker received a PhD in biochemistry and molecular biology from the University of Calgary.

Willow Biosciences Inc. (OTCQB: CANSF), closed Thursday's trading session at $0.55, off by 3.4071%, on 4,150 volume with 6 trades. The average volume for the last 3 months is 10,404 and the stock's 52-week low/high is $0.400999993/$2.1775.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.